| Q40061923 | Adjunctive therapies in severe sepsis and septic shock: current place of steroids |
| Q36241197 | Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control. |
| Q64996429 | Behçet's Disease: Pulmonary Aneurysm Resolution with Oral Therapy and HLA B72 Allele Association. |
| Q22305498 | Blood glucose control in patients with severe sepsis and septic shock |
| Q42113256 | Bolus or continuous hydrocortisone--that is the question |
| Q58791686 | Corticosteroid therapy for sepsis: a clinical practice guideline |
| Q90666843 | Corticosteroids for Septic Shock: Another Chapter in the Saga |
| Q39387531 | Corticosteroids for severe sepsis: an evidence-based guide for physicians |
| Q24187207 | Corticosteroids for treating sepsis |
| Q24247427 | Corticosteroids for treating severe sepsis and septic shock |
| Q90312235 | Corticosteroids in Acute Lung Injury: The Dilemma Continues |
| Q39223133 | Evaluation of Hydrocortisone Continuous Infusion Versus Intermittent Boluses in Resolution of Septic Shock |
| Q94545085 | General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections |
| Q91910648 | Glucocorticoids in the treatment of acute respiratory distress syndrome |
| Q90680354 | Impact and Beneficial Critical Points of Clinical Outcome in Corticosteroid Management of Adult Patients With Sepsis: Meta-Analysis and GRADE Assessment |
| Q37124621 | Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia. |
| Q55710717 | Impact of corticosteroid administration in septic shock on glycemic variability. |
| Q35975694 | Life-threatening ANCA-positive vasculitis associated with rickettsial infection |
| Q35566940 | Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study. |
| Q90318438 | Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery |
| Q37734444 | Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome |
| Q37590213 | Revisiting steroid treatment for septic shock: molecular actions and clinical effects--a review |
| Q26744591 | The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update |
| Q36449389 | The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery |
| Q90074528 | The role of glucocorticoids as adjunctive treatment for sepsis in the modern era |
| Q54254903 | Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. |
| Q34153235 | Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. |
| Q34871137 | Which variables are associated with blood glucose levels outside the target range in surgical critically ill patients? A retrospective observational study |
| Q33338424 | Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis |
| Q83340506 | [Corticosteroid insufficiency in the critically ill. Pathomechanisms and recommendations for diagnosis and treatment] |